Electromed (ELMD) Gains from Investment Securities (2024 - 2026)
Electromed's (ELMD) quarterly Gains from Investment Securities came in at -$94000.0 in Q1 2026, up 72.19% year-on-year from -$54591.1 in Q1 2025, and down 327.27% on a QoQ basis from -$22000.0 in Q4 2025.
Electromed (ELMD) Gains from Investment Securities (2024 - 2026) Analysis & Trends
Electromed (ELMD) has 3 years of Gains from Investment Securities data on file, last reported at -$94000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Electromed | 327.67 Mn | 310.68 Mn | 14.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94,000.00 |
| Mar 31, 2026 | -94,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Dec 31, 2025 | -22,000.00 |
| Sep 30, 2025 | -81,000.00 |
| Sep 30, 2025 | -81,000.00 |
| Mar 31, 2025 | -338,000.00 |
| Mar 31, 2025 | -338,000.00 |
| Dec 31, 2024 | -135,000.00 |
| Dec 31, 2024 | -135,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Mar 31, 2024 | -99,000.00 |
| Mar 31, 2024 | -99,000.00 |